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Introduction
Diabetes mellitus is a common metabolic disease that 
is increasing in prevalence worldwide. This increase 
has highlighted the importance of understanding both 
the complications and metabolic consequences of 
the condition.1 Africa is estimated to experience the 
second highest increase in prevalence of diabetes 
in the world. The greatest surge is expected to occur 
within the next 15-20 years.2,3 
According to Hedefort et al, there has been a fourfold 
leap in the number of foot ulcerations that affect 
patients with type 2 diabetes mellitus.4 It follows that 
there is an expected increase in the number of patients 
who suffer from the complications that are associated 
with diabetes mellitus. The literature stipulates that the 
lifetime risk of developing a diabetic ulcer can be as 
high as 13-25%.5,6 It is important to acknowledge that 
diabetes predisposes the patient to the development 
of lower limb lesions since the foot is a target of 
peripheral neuropathy and ischaemia.1,7 Chronic 
diabetic foot ulcerations are known to be a notorious 
problem in patients with diabetes mellitus. Nonhealing 
ulcerations are associated with substantial cost and 
poor outcomes generally, such as decreased quality 
of life and nontraumatic lower limb amputations. The 
nature of chronic diabetic foot ulcerations disables the 
normal stages of healing, which in turn induces a state 
of pathological inflammation. This results in the overall 
healing process becoming incomplete or delayed.8 
The disabled healing process has become a significant 
problem within the diabetic community, since it 
predisposes patients to secondary infections. More 
than 12% of this population undergo possible lower limb 
amputations.9 Diabetic lower limb ulcerations tend to 
heal slowly and require intensive multidisciplinary care. 
The management of chronic diabetic foot ulcerations 
requires a consistent and reliable treatment plan.10
Peripheral sensory neuropathy is a major contributor 
to diabetic foot ulcerations, and is frequently the most 
common microvascular complication of both type 1 
and type 2 diabetes. It is progressive and irreversible.11 
Neuropathy alone cannot induce ulceration as it 
is not sufficient. Trauma acts as an accomplice to 
neuropathy. Consequently, it is vital to understand that 
the loss of sensation in high-pressure areas predisposes 
a patient to ulcers and hinders wound healing.
Ischaemia is one of the most destructive complications 
of diabetes. It has become clear that this condition 
may predispose a patient to ulcerations, as well as 
gangrene, which may result in lower limb amputations. 
The literature has shown that endothelial and smooth 
muscle cell dysfunction contributes to impaired 
microcirculation in patients with diabetes. The red blood 
cells become less flexible as a result of glycosylation. 
This increases the risk of obstruction within the blood 
vessels and reduces the rate of perfusion. Disturbed 
microcirculation, in association with neuropathy, is 
linked to the development of diabetic gangrene, 
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and ulcerations and infections of both the skin and 
the bones in patients with long-term diabetes.12,13 
Impairment of the small blood vessels in parts of the 
body may also induce poor wound healing. 
Although infection may not be a primary cause of 
diabetic ulcers in the lower extremities, it is a major 
contributor to non-healing wounds in patients with 
diabetes. It is important to comprehend that these 
patients are at greater risk and require constant 
monitoring. Patients with diabetes are often unable to 
respond appropriately to an infection. Local signs, such 
as pain and erythema, can be less apparent, because 
of factors such as neuropathy and ischaemia.10 
Phototherapy 
The application of phototherapy or low-level laser 
therapy (LLLT) has generated considerable interest 
within surgery, dentistry, dermatology, somatology, pain 
management and wound healing. It is a therapeutic 
method that involves  the application of laser light, at 
a particular wavelength and at low intensities, to the 
tissue to stimulate biological processes. The choice of 
wavelength is dependent on the depth of penetration. 
In some instances, light from light-emitting diodes (LEDs) 
is used. It is important to understand that the effects of 
LLLT arise because of chemical and biological changes 
within a cell, and not because of thermal changes. 
Photon energy is absorbed by photoacceptors or 
chromophores within a cell. The main photoacceptor 
is thought to be the mitochondrion. Research has 
shown that following laser irradiation, there is an 
increase in mitochondrial metabolism.14 This leads to an 
escalation in adenosine triphosphate (ATP)15,16 and cell 
membrane permeability, which leads to the activation 
of secondary messengers. In turn, these activate a 
cascade of intracellular signals.17 Numerous studies 
have established the effect of phototherapy in vitro 
and in vivo, as well as in animal studies. Despite this, 
LLLT is still not an established treatment modality. This is 
mainly owing to poorly controlled studies and a lack of 
knowledge of the underlying mechanisms. 
Effect of LLLT on diabetic ulcers
Phototherapy has been shown to positively affect the 
healing process in wounds that are associated with 
diabetes.18 Several studies have acknowledged that 
LLLT stimulates angiogenesis and microcirculation 
and promotes vasodilation, thereby improving blood 
circulation and reducing tissue damage that is caused 
by ischaemia.13,19-21
In vitro studies
A review of the literature that was published between 
2002 and 2009 by Peplow et al showed that there was 
a clear positive effect on cells when LLLT was applied.22 
LLLT stimulated cellular proliferation in a wide variety 
of cell types, including fibroblasts, endothelial cells, 
smooth muscle cells, stem cells, osteoclasts, osteoblasts 
and keratinocytes.
According to the literature, phototherapy stimulates 
mitochondrial oxidative metabolism in vitro, and 
increases cell and tissue repair in vivo. In vitro 
experimentation has demonstrated a significant 
increase in cell growth in a variety of cell lines 
which include murine fibroblasts, rat osteoblasts, rat 
skeletal muscles and normal human epithelial cells.23 
AlGhamdi et al conducted a review of the literature 
and suggested that a dose of 0.5-4.0 J/cm2, and 
a wavelength ranging from 600-700 nm, were the 
most beneficial and helpful in enhancing cellular 
proliferation.24 At the correct laser parameters, LLLT has 
been shown to positively stimulate diabetic-wounded 
fibroblast cells. An increase in viability, proliferation, ATP, 
growth factors, cytokines and nitric oxide results, as well 
as a decrease in cellular damage and proinflammatory 
cytokines.25-28 A study conducted by Gavish et al29 on 
smooth muscle cells demonstrated that LLLT stimulated 
proliferation and collagen synthesis, and modulated 
equilibrium between the degradation and synthesis 
of the extracellular matrix; a very important aspect in 
diabetic wound healing. LLLT has a direct influence on 
the mitochondria of irradiated cells.14,30,31 This results in 
increased ATP production which leads to the release of 
secondary messengers and the modulation of cellular 
processes, leading to cell survival and repair. 
Animal studies
Several studies have been conducted on animals 
with diabetes to evaluate the effects of phototherapy 
on the healing process of diabetic wounds. Positive 
results have been shown in wound healing in mice with 
diabetes.32-35
Peplow et al conducted a review of the literature 
on the use of phototherapy in wound healing in 
diabetic rat and mice animal models. Their review 
consistently showed that phototherapy was able to 
stimulate wound healing and that there is a strong 
case for further controlled studies in vitro. Kawalec et 
al32 and Agnol et al36 showed that LLLT has the ability 
to significantly reduce the size of a wound that was 
inflicted in diabetic mice and rats respectively. Al-
Watban37 demonstrated that streptozotocin-induced 
diabetic rat burns and wounds responded favourably 
to irradiation at a wavelength of 633 nm. Akyol et al38 
made use of a laser, not only to induce a wound, but 
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also to treat the wound, in male diabetic Wistar rats. 
They found that wounds created by a scalpel healed 
slower than those induced by a laser. They also noted 
that wounds treated with LLLT had the least amount of 
tissue injury and the fastest resolution of inflammatory 
response, as determined histologically. 
Rabelo et al39 irradiated full-thickness wounds in 
streptozotocin-induced diabetic rats (632.8 nm). 
They found that irradiation promoted efficient wound 
healing at a faster rate than in control rats. It has been 
shown that a single treatment of LLLT (wavelength of 
660 nm, fluence of 4 J/cm2) is enough to accelerate 
the inflammatory phase, angiogenesis and leukocyte 
chemotaxis in burn wounds on the backs of rats.40 
At a wavelength of 890 nm (pulsed at a frequency 
of 80 Hz) and a fluence of 0.2 J/cm2 per point, LLLT 
has been found to increase wound tensile strength 
in diabetic rats. A fluence of 0.03 J/cm2 per wound 
point decreased wound tensile strength.41 There was 
a significant improvement in the maximum stress and 
repair of tenotomised Achilles tendons in diabetic 
rats who were exposed for 10 consecutive days to a 
wavelength of 632.8 nm and a fluence of 2.9 J/cm2.42 
A recent study has shown that the consequences of 
irradiation on diabetic wound healing in mice was 
not as a result of the effects on the plasma glucose 
levels. LLLT did not have a hypoglycaemic effect. The 
effects on wound healing relate directly to cellular and 
biochemical changes that are induced at the wound 
site.43 Not all studies have shown positive effects. 
Abdi et al44 found that laser irradiation (632.8 nm) 
did not enhance bone repair of a partial transversal 
standardised osteotomy in streptozotocin-induced 
diabetic rats. 
In vivo studies
Accelerated wound healing has been observed in vivo 
following phototherapy. It resulted in increased rates of 
epithelisation in human studies45 and the promotion of 
connective tissue stability.46 Recent studies using laser 
to treat diabetic foot complications demonstrated a 
positive effect on wound healing. According to a study 
that was conducted by Schindl et al, phototherapy 
improved microcirculation at the irradiated site, and 
caused a systemic effect on microcirculation, thereby 
improving the skin circulation.13 A study conducted 
on 30 Egyptian patients with diabetic-linked skin 
lesions (dryness, hair loss, infections, itching, eczema 
and nail changes) showed that combined irradiation 
of the affected area with visible red and infrared 
lasers improved blood flow and partially reversed the 
condition in the affected area.47
In a double-blinded, randomised, placebo-controlled 
experimental trial, Minatel et al treated the chronic 
diabetic leg ulcers of 23 patients that were unrespon-
sive to other forms of treatment.48 Thirteen ulcers were 
treated with phototherapy (combined 660 and 890 nm) 
twice a week until healed, or for a maximum period of 
three months. The rest were sham irradiated (10 ulcers). 
In the group of ulcers that were irradiated, 58.3% re-
solved completely, and 75% of the ulcers achieved 90-
100% healing by day 90. Minatel et al found that photo-
therapy promotes tissue granulation and rapid healing 
of diabetic ulcers.48 
In another study, Caetano et al used phototherapy 
(combined 660 and 890 nm) in a randomised, 
placebo-controlled, double-blinded study to treat 
venous ulcers that failed to respond to other forms of 
treatment.49 A total of 32 ulcers were divided into three 
groups. Group 1 (a total of 11 ulcers) received placebo 
irradiation. Wounds were cleaned and dressed with 
1% silver sulphadiazine cream. In Group 2 (a total of 
14 ulcers), the wounds were irradiated twice a week 
and the wounds dressed with 1% sulphadiazine. In 
Group 3 (a total of seven ulcers), the wounds were 
dressed with 1% sulphadiazine. Treatment continued 
for three months. Seven of the 32 ulcers were small in 
size and healed within 60 days, regardless of treatment. 
The remaining ulcers (medium and large sized) were 
compared, and on days 30, 60 and 90 respectively, 
75%, 50% and 75% of the medium-sized ulcers in Group 
2 had healed, compared to 0%, 33% and 67% of ulcers 
in Group 1. None of the ulcers in Group 3 had healed. 
A comparison of the large ulcers showed that 0%, 43% 
and 57% of ulcers in Group 2 had healed, and 0%, 20% 
and 20% of ulcers in Group 1, while none of the ulcers 
in Group 3 had healed at the same time points. It was 
evident that medium- and large-sized ulcers that were 
treated with phototherapy had a ≥ 40% faster healing 
rate per month.49
The literature has clearly indicated that phototherapy 
has the ability to help to resolve chronic diabetic 
lower limb ulcerations. In a recent study, 30 male 
and female patients with diabetes were divided into 
two equal groups, comprising a control group and a 
laser-treated group (850 nm). Patients were treated 
over a four-week period. Patients who received 
phototherapy experienced a 26.4% decrease in pain 
levels, while electrophysiological parameters and foot 
skin microcirculation were significantly improved.50 
This shows that phototherapy may have the ability to 
improve the electrophysiological parameters of the 
peroneal motor nerve and the sural sensory nerve, 
resulting in decreased pain intensity.50 This is very 
beneficial, even though the exact mechanism of pain 
relief that is induced by phototherapy is still largely 
unknown. Even though very little clinical research has 
been carried out on laser therapy and diabetic ulcers, 
Schindl et al noted that this treatment modality might 
constitute a side-effect-free route for the healing of 
neuropathic ulcers in patients with diabetes.51
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Effect of LLLT on infection and inflammation 
Different wavelengths are used for different appli-
cations in phototherapy. This is based largely on the 
wavelengths’ penetrative depths into the tissue, as 
well as their absorption properties. Light in the visible 
red to near-infrared spectrum has been shown to be 
absorbed by cytochrome c oxidase, while light in the 
blue spectrum is absorbed by flavins.52 Blue light has 
been shown to have bactericidal effects. Enwemeka 
et al established that blue light (470 nm) was able to 
kill methicillin-resistant Staphylococcus aureus (MRSA) 
in vitro.53 This is an important breakthrough, since the 
treatment of MRSA is extremely difficult. A number 
of other studies have found that blue light is bacteri-
cidal to Propionibacterium acne,54 S. aureus55 and 
Pseudomonas aeruginosa.55 Lipovsky et al revealed 
that high-intensity visible light in the range of 400- 
1 000 nm was bactericidal to several pathogenic bac-
teria, namely S. aureus, P. aeruginosa, Escherichia coli 
and Serratia marcescens.56 Ankri et al showed that a 
wavelength of 480 nm LLLT was optimal when treat-
ing infected wounds and should be used first, followed 
by irradiation at 730 nm to enhance wound closure.52 
Further studies should be conducted, as it may be use-
ful to use a combination of wavelengths in the treat-
ment of infected diabetic foot ulcers.
It has been established that mast cells play an 
important role in wound healing, as well as in the 
inflammation process. LLLT may have an influence on 
mast cells and result in their degranulation,57 together 
with the production of several cytokines that are 
contained within their cytoplasmic granules. Xavier et 
al showed that phototherapy reduces inflammation 
in collagenase-induced tendinitis in rats.58 Post-
irradiation (LED 880 nm), there was a reduction in the 
amount of inflammatory cells, as well as a decrease 
in inflammatory cytokines interleukin-1 beta (IL-1b), 
IL-6, tumour necrosis factor alpha (TNF-a) and cyclo-
oxygenase 2. Aimbre et al investigated the effect of 
LLLT on immune modulation (TNF-a) in bronchoalveolar 
fluid after immune complex-induced lung injury in male 
Wistar rats.59 They also found that at the correct dose, 
LLLT was able to significantly reduce TNF-a. Rabelo et 
al reported that irradiated streptozotocin-induced 
diabetic rats (632.8 nm) had a less intense inflammatory 
response.39 Sekhejane et al investigated the effect 
of LLLT (636 nm) on proinflammatory cytokines, IL-1b, 
IL-6 and TNF-a, in a diabetic and hypoxic fibroblast 
cell model in vitro.60 They demonstrated a decrease 
in these cytokines and the translocation of nuclear 
factor kappa B. There was also an increase in the 
proliferation of these cells as they were directed into a 
cell survival pathway. Gavish et al demonstrated that 
the irradiation of porcine smooth muscle cells inhibited 
proinflammatory cytokine IL-1b.29
Conclusion
Phototherapy or LLLT may be considered from a range 
of alternative treatment options, such as biological 
therapies, hyperbaric oxygen and negative-pressure 
therapy, which help to enhance the wound healing 
process. However, in practice, the management of 
diabetic lower limb ulcerations depends on clinicians 
and available resources. It is important to note that 
new technologies are not optimally effective unless 
they are coupled with appropriate overall wound 
management. The scientific community is dependent 
on comprehensive wound care studies in order 
to establish standard guidelines when assessing 
new approaches to chronic wound management. 
Standard treatments for diabetic lower limb ulcers 
seem to be ineffective and to reduce the quality of life 
of most patients.61 In the last 20 years, new treatment 
procedures have been developed and tested. These 
have resulted in minimal improvements to previously 
available treatment options.49 The clinical application 
of phototherapy is still to be fully investigated. It is 
unfortunate that more well-controlled clinical studies 
have not been explored in the past. Phototherapy 
has been evaluated as noninvasive and constitutes 
a promising treatment option with which to treat 
diabetic wounds.32,62 If phototherapy can be shown 
to have beneficial effects on chronic diabetic lower 
limb ulcerations, and if the underlying mechanisms 
are better understood, the treatment regime could be 
reconstructed and improved. 
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